Teligent, Inc. to Hold Conference Call for First Quarter 2020 Results on Friday May 22nd, 2020
Teligent, Inc. (NASDAQ: TLGT) will hold a conference call on May 22, 2020, at 8:00 AM ET to discuss its Q1 2020 financial results and business updates.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Teligent, Inc. (NASDAQ: TLGT) will hold a conference call on May 22, 2020, at 8:00 AM ET to discuss its Q1 2020 financial results and business updates. Participants can join by dialing (866) 393-8366 for U.S. listeners or (409) 350-3154 for international callers. The call will also be available via webcast in the Investor Relations section of Teligent's website.
Teligent specializes in the specialty generic pharmaceutical market, aiming to establish itself as a key player in this sector.
Positive
- Scheduled conference call to discuss Q1 2020 financial results may boost investor confidence.
- Focus on specialty generic pharmaceuticals positions the company in a niche market.
Negative
- None.
Details
News Market Reaction – TLGT
The recorded move for TLGT in the trading session of this news was -4.83%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BUENA, N.J., May 19, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00AM ET on Friday May 22nd, 2020 to discuss the 1st quarter 2020 financial results and business update.
The Company invites you to listen to the call by dialing (866) 393-8366. International participants should call (409) 350-3154. Participants should ask to join the Teligent, Inc. call.
This call is available via webcast and can be accessed under News & Events in the Investor Relations section of Teligent, Inc.'s website at www.teligent.com.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
| Contact: | Damian Finio |
| Teligent, Inc. | |
| (856) 336-9117 | |
| www.teligent.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.